Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 435-030-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment. GLP-deviation: the stability of the test substance has not been reported.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 435-030-7
- EC Name:
- -
- Cas Number:
- 26452-81-3
- Molecular formula:
- C5H5N2OCl
- IUPAC Name:
- 4-chloro-6-methoxypyrimidine
- Test material form:
- other: solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: Males 260 - 360 g; females 180 - 215 g
- Fasting period before study: No
- Housing: Individually, in cages suitable for animals of this strain and the weight range expected during the course of the study
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days prior to dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): ≥15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorso-lumbar region
- Type of wrap if used: a foil backed gauze patch, held in position by a cohesive bandage secured with two pieces of surgical tape.
REMOVAL OF TEST SUBSTANCE
- Washing: absorbent cotton wool soaked in clean warm water and dried with clean tissue paper
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amounts applied: 500, 750 or 1000 mg/kg
- Constant volume or concentration used: no
- For solids, paste formed: yes
VEHICLE
- Amount applied: 0.2 - 0.4 mL - Duration of exposure:
- 24 hours
- Doses:
- 500, 750, 1000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations: prior to dosing, at least twice following dosing on day 1, thereafter once daily. Weighing on day of dosing (day 1) and days 8 and 15.
- Necropsy of survivors performed: yes, macroscopic examination. - Statistics:
- For males, the acute dermal median lethal dose was estimated from the mortality data (the mortality data included animals that were killed in extremis) by linear log-dose interpolation using nominal dose values. Confidence limits are given by the highest dose with no mortalities and the lowest dose with 100% mortality,
For females, the acute dermal median lethal dose was estimated from the mortality data (the mortality data included animals that were killed in extremis) by logistic regression using nominal dose values. Confidence limits were calculated using a likelihood ratio interval.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 612 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 500 - 750
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 709 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 606 - 828
- Mortality:
- Following a dose of 500 mg/kg, none of the animals died.
Following a dose of 750 mg/kg, all the males were killed in extremis on days 1 or 2 and three of the females were found dead on day 2.
Following a dose of 1000 mg/kg, all the animals were killed in extremis on day 1. - Clinical signs:
- other: Following a dose of 500 mg/kg, signs of slight systemic toxicity were seen in all animals, with decreased activity, lacrymation, salivation and upward curved spine observed in most animals. Other signs such as miosis, stains around mouth and nose and side
- Gross pathology:
- Following a dose of 500 mg/kg, there were no macroscopic abnormalities at examination post mortem.
Following a dose of 750 mg/kg, there were no macroscopic abnormalities in the surviving animals. One male and one female had an eye discharge. The same male and another female had stained nares and one female had a discoloured thymus. These are all non-specific findings but are considered to be treatment-related. One male had a white deposit in the bladder which is considered to be a spontaneous finding and unrelated to treatment.
Following a dose of 1000 mg/kg, one male had a discoloured thymus. As above, this is a nonspecific, but treatment-related finding. Two males had pelvic dilatation of the kidney which is considered to be a spontaneous finding and unrelated to treatment.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal median lethal dose of the test substance is estimated to be 612 mg/kg and 709 mg/kg to male and female rats respectively.
- Executive summary:
In this acute dermal toxicity study in rats, according to OECD guideline 402, and GLP, groups of five male and five female Alpk:APrSD (Wistar-derived) rats received a single dermal application of 500, 750 or 1000 mg/kg of test substance. Test substance was moistened to a dry paste with a small amount of water and applied to shaved skin and kept in contact with skin using an occlusive dressing for approximately 24 hours after which the skin was cleansed free of test substance. Surviving animals were assessed daily for the following 14 days for any signs of systemic toxicity and their body weights were recorded at intervals of 1 week throughout the study. Animals in extremis and those surviving to the end of the study were killed and, together with those found dead, were subjected to a macroscopic examination. Following a dose of 500 mg/kg, none of the animals died. Signs of slight systemic toxicity were seen in all animals, with complete recovery by day 4. All animals showed an overall body weight gain during the study. There were no macroscopic abnormalities. Slight skin irritation was seen in three males and all the females, but had completely resolved by day 13. Following a dose of 750 mg/kg, all the males were killed in extremis on days 1 or 2 and three of the females were found dead on day 2. The surviving females showed signs of slight systemic toxicity, with complete recovery by day 3; both showed an overall body weight gain during the study. At examination postmortem, treatment-related abnormalities were seen in one male and the three females killed in extremis and comprised eye discharge, staining of the nares, and discolouration of the thymus. There were no macroscopic abnormalities in the surviving females. Slight skin irritation was seen on day 2 in one male. Following a dose of 1000 mg/kg, all the animals were killed in extremis on day 1. At examination postmortem one male had a discoloured thymus. In conclusion, the acute dermal median lethal dose of the test substance is estimated to be 612 mg/kg (95% confidence limits 500, 750) to male rats and 709 mg/kg (95% confidence limits 606, 828) to female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.